The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of "“Targeting protein kinase CK2 in the treatment of cholangiocarcinoma”.
No. |
Publication Date |
Citing Article |
1 |
2022 |
Saini Wang, Anil Kumar Yadav, Jin-Yi Han, Keun Soo Ahn, Byeong-Churl Jang. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α, International Journal of Molecular Sciences. 2022; 23: 6353. https://doi.org/10.3390/ijms23116353 |
2 |
2024 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Denis Tümen, Martina Müller, Arne Kandulski. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma, Cancers. 2024; 16: 1690. https://doi.org/10.3390/cancers16091690 |